Literature DB >> 34222995

Inclusion of next-generation leaders and cost-effective precision diagnostic techniques are vital in combatting antimicrobial resistance in low- and middle-income countries.

Krishna Prasad Acharya1, Supram Hosuru Subramanya2, Johann D D Pitout3,4.   

Abstract

Entities:  

Year:  2020        PMID: 34222995      PMCID: PMC8210119          DOI: 10.1093/jacamr/dlaa032

Source DB:  PubMed          Journal:  JAC Antimicrob Resist        ISSN: 2632-1823


× No keyword cloud information.
Sir, Various reports have highlighted the importance of global commitment and consensus to strengthen collaboration for sustainable governance of global antimicrobial stewardship. Regarding the issue of antimicrobial resistance (AMR), despite the different circumstances that every country is facing, they share the common issue of the growing burden of AMR. An inter-disciplinary global momentum, involving high-level political willingness, continuous multi-sectoral and multi-stakeholder discussions, improved surveillance systems and the strict implementation of a monitoring and evaluation framework through a One Health approach, would be effective to control and contain AMR across the world. However, the inter-sectoral collaboration between One Health stakeholders like animal health, human health and environmental health professionals are underdeveloped in low- and middle-income countries (LMICs). Despite some initial efforts of governmental and non-governmental organizations to promote inter-sectoral collaboration to combat AMR, very little progress has been made to date., Here we propose some simple yet crucial initiatives for combatting AMR problems in LMICs by fostering a comprehensive communication strategy. Firstly, raising awareness among the general public, policymakers, prescribers, farmers and other stakeholders at regional and national levels regarding AMR issues will be beneficial in improving behavioural change and in promoting inter-sectoral communication among various One Health stakeholders. Similarly, increasing the level of awareness and knowledge of the importance of improved sanitation and hygiene as well as improving infection prevention and control (IPC) practices could be the cornerstones of prevention, control and containment of AMR., A study by Ershova et al. in Russia has shown that awareness of healthcare professionals of good IPC practices and implementation of such measures in the neuro-ICU has reduced nosocomial infection by 200%. Similarly, other studies have also shown a significant effect of the awareness of improved sanitation and hygiene on lowering the burden of AMR., Mass AMR awareness can be achieved by using digital and social media platforms like Facebook, Twitter, Instagram, FM radio, newspapers, regional magazines etc. These social media platforms can reach large audiences in a short duration of time, which could create momentum for controlling AMR. The data published by techjury (https://techjury.net/stats-about/mobile-gaming/#gref) suggest that the number of active mobile gamers worldwide was approximately 2.2 billion in 2019 and users spend more than 43% of their ‘smartphone time’ playing games. Therefore, designing new AMR-related smartphone games seems to be a novel, innovative and feasible idea. Additionally, AMR-themed movies and advertisements would play a significant role in reaching a larger audience and influencing their thoughts. Secondly, introducing AMR-related topics in school and college curricula could provide some insights into the growing minds of students and trigger a mindset change at a young age. This will enable a new generation to benefit from a better understanding of the root causes of AMR and therefore change the mindsets and behaviour of people. Schoolchildren and college students would be able to advise their family members to use antibiotics more rationally and improve sanitation and hygiene, even when their family members are illiterate and are out of the reach of awareness campaigns and programmes on AMR issues. So, such strategies could be cost-effective approaches for combatting AMR at large and are especially relevant for LMICs., Thirdly, LMICs bear a considerable burden of MDR bacteria, but they lack adequate phenotypic and genomic diagnostic tools and surveillance systems to curb the spread of such bacteria. LMICs urgently need on-site rapid, accurate and cost-effective phenotypic and genomic technologies to identify country/region-specific AMR determinants., The methodologies should be timely, simple, user-friendly and accordant with local economic and social constraints. Such precision diagnostic techniques can efficiently be utilized by LMICs to identify potential nosocomial outbreaks in a real-time fashion in a cost-effective manner. This will enable IPC personnel to rapidly implement effective measures to limit the spread of resistant bacteria in the LMIC hospital setting. In conclusion, to conquer AMR in LMICs, we propose innovative ideas for raising AMR awareness and promoting behavioural changes in the general population by using mass media. The inclusion of next-generation leaders seems to be an ideal, innovative and cost-effective pathway to combat AMR threats. Additionally, early detection and control of the spread of high-risk clones by the precise use of genomic surveillance systems in LMICs are crucial.

Funding

This study was carried out as part of our routine work.

Transparency declarations

None to declare.

Supplementary data

Reviewer report 1 is available as Supplementary data at JAC-AMR Online. Click here for additional data file.
  8 in total

1.  A roadmap for sustainably governing the global antimicrobial commons.

Authors:  Susan Rogers Van Katwyk; Manica Balasegaram; Pete Boriello; Jeremy Farrar; Alberto Giubilini; Mark Harrison; Marie-Paule Kieny; Claas Kirchhelle; Joanne Liu; Kevin Outterson; Muhammad Ali Pate; Mathieu Poirier; John-Arne Røttingen; Julian Savulescu; Rebecca Sugden; Visanu Thamlikitkul; Isaac Weldon; Sally Davies; Steven J Hoffman
Journal:  Lancet       Date:  2019-11-16       Impact factor: 79.321

2.  The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori; V P Munn; T M Hooton
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

3.  AMR Surveillance in low and middle-income settings - A roadmap for participation in the Global Antimicrobial Surveillance System (GLASS).

Authors:  Anna C Seale; N Claire Gordon; Jasmin Islam; Sharon J Peacock; J Anthony G Scott
Journal:  Wellcome Open Res       Date:  2017-09-26

4.  Mapping global policy discourse on antimicrobial resistance.

Authors:  Didier Wernli; Peter S Jørgensen; Chantal M Morel; Scott Carroll; Stephan Harbarth; Nicolas Levrat; Didier Pittet
Journal:  BMJ Glob Health       Date:  2017-07-13

5.  The effects of training inpatients and their relatives about infection control measures and subsequent rate of infection.

Authors:  Funda Ozturkan Erdek; Ciler Keles Gozutok; Yeliz Dogan Merih; Aysegul Aliogulları
Journal:  North Clin Istanb       Date:  2017-05-10

6.  Evidence needed for antimicrobial resistance surveillance systems.

Authors:  Cécile Aenishaenslin; Barbara Häsler; André Ravel; Jane Parmley; Katharina Stärk; David Buckeridge
Journal:  Bull World Health Organ       Date:  2019-01-28       Impact factor: 9.408

7.  Antimicrobial resistance - moving forward?

Authors:  Marta Lomazzi; Michael Moore; April Johnson; Manica Balasegaram; Bettina Borisch
Journal:  BMC Public Health       Date:  2019-07-02       Impact factor: 3.295

8.  Implementing an infection control and prevention program decreases the incidence of healthcare-associated infections and antibiotic resistance in a Russian neuro-ICU.

Authors:  Ksenia Ershova; Ivan Savin; Nataliya Kurdyumova; Darren Wong; Gleb Danilov; Michael Shifrin; Irina Alexandrova; Ekaterina Sokolova; Nadezhda Fursova; Vladimir Zelman; Olga Ershova
Journal:  Antimicrob Resist Infect Control       Date:  2018-07-31       Impact factor: 4.887

  8 in total
  1 in total

1.  Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015-2017.

Authors:  Gisele Peirano; Liang Chen; Diego Nobrega; Thomas J Finn; Barry N Kreiswirth; Rebekah DeVinney; Johann D D Pitout
Journal:  Emerg Infect Dis       Date:  2022-05       Impact factor: 16.126

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.